Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2008
11/06/2008US20080274989 Rna Interference Suppression of Neurodegenerative Diseases and Methods of Use Thereof
11/06/2008US20080274978 Tryptophan rich mimics; antiinflammatory agents; drug screening for formyl peptide receptor like 1 (FPRL1) activity; arthritis, autoimmune disorders, Alzheimer's disease
11/06/2008US20080274976 Uses of novel potassium channel blockers
11/06/2008US20080274975 Human A beta binding alcohol dehydrogenase (ABAD) inhibitors; amino acid sequence 94-114 of ABAD; Alzheimer's disease; reducing free radical generation, DNA fragmentation and cytochrome C cellular release; preserving cell viability
11/06/2008US20080274202 Compositions and Method for Brain Specific Targeted Delivery of Therapeutic Agents
11/06/2008US20080274167 Impermeable backing layer, an active substance layer of sufentanyl and a polymer mixture with microreservoirs dispersed, an active substance dissolved in the microreservoirs
11/06/2008US20080274131 Molecular antigen arrary
11/06/2008US20080274124 Polyunsaturated fatty acids; kits
11/06/2008US20080274118 CD40 specific immunoglobulin for prevention and treatment of arthritic, cardiovascular, allergic, neurodegenerative and/or blood disorders
11/06/2008US20080274103 Adenylyl Cyclase Antibodies, Compositions and Uses Thereof
11/06/2008US20080274098 Method of Treating or Preventing Tissue Deterioration, Injury or Damage Due to a Neuro-, Muscular- or Neuro-Muscular-Degenerative Disease, or Restore Tissue Adversely Affected by Said Disease
11/06/2008US20080274096 Fusion Proteins Having a Modulated Half-Life in Plasma
11/06/2008US20080274093 Cell culture comprises astrocytes with induced antioxidant response element (ARE) mediated transcription; Alzheimer's disease, Huntington's disease, Parkinson's disease
11/06/2008US20080274089 Inflammation
11/06/2008US20080274087 Cultured pluripotent animal cell which express CD13 and CD90 for use in treatment and prevention of ischemic injury; regenerative medicine, tissue engineering and repair
11/06/2008US20080274077 Using Nogo receptor suppressant as therapeutic in treatment of nervous system and neurodegenerative disorders; axonal regeneration
11/06/2008US20080274058 substrates for amyloidogenic proteins, for example, A beta 1-42, an amyloid protein, brain deposits of which are associated with Alzheimer's disease
11/06/2008DE102007020493A1 Substituierte Amid-Derivate Substituted amide derivatives
11/06/2008DE102007020492A1 Substituierte Sulfonamid-Derivate Substituted sulfonamide derivatives
11/06/2008CA2685593A1 Combination pharmaceutical compositions
11/06/2008CA2685591A1 Pharmaceutical nimodipine compositions
11/06/2008CA2685507A1 Substituted sulfonamide derivatives
11/06/2008CA2685503A1 Substituted amide derivatives
11/06/2008CA2685344A1 Deuterium labelled ketamine
11/06/2008CA2685247A1 New 4,8-diphenyl-polyazanaphthalene derivatives
11/06/2008CA2685131A1 Stable solid preparation containing 4,5-epoxymorphinan derivative
11/06/2008CA2685126A1 Therapeutic or prophylactic agent for dyskinesia
11/06/2008CA2683887A1 Aminodihydrothiazine derivatives substituted with a cyclic group
11/06/2008CA2683159A1 Isoquinolinone derivatives as nk3 antagonists
11/06/2008CA2682519A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008CA2682400A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008CA2667621A1 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
11/05/2008EP1988397A1 Compositions and method for stabilizing transthyretin and inhibiting transthyretin misfolding
11/05/2008EP1988395A1 Methods for evaluating tissue morphogenesis and morphogenic activity
11/05/2008EP1988091A1 Tricyclic compounds
11/05/2008EP1988081A1 Binding inhibitor of sphingosine-1-phosphate
11/05/2008EP1988077A1 Nirogenous heterocyclic derivatives substituted with cyclic groups
11/05/2008EP1987844A1 Adhesive patch for external use with improved cohesive force and sustained-release characteristics
11/05/2008EP1987842A1 Cell proliferation inhibitor
11/05/2008EP1987834A2 Substituted piperidines as therapeutic compounds
11/05/2008EP1987832A1 Sustained-release tablet composition of pramipexole
11/05/2008EP1987823A1 Condensation aerosol containing zaleplon for inhalation
11/05/2008EP1987815A1 Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
11/05/2008EP1987066A2 Methods for treating autoimmune or demyelinating diseases
11/05/2008EP1987064A1 Domain antibody construct
11/05/2008EP1987034A1 Spiro condensed piperidnes as modulators of muscarinic receptors
11/05/2008EP1987033A1 Novel diazabicycloalkane derivatives and their medical use
11/05/2008EP1987032A1 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists
11/05/2008EP1987031A1 3-heteroaryl- 3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists
11/05/2008EP1987029A1 Enantiopure quinuclidinyloxy pyridazines and their use as nicotinic acetylcholine receptor ligands
11/05/2008EP1987019A1 Benzoyl-piperidine derivatives as 5ht2/d3 modulators
11/05/2008EP1987017A1 Radioligands for the 5 -ht1b receptor
11/05/2008EP1987009A1 Cyclourea compounds as calcium channel blockers
11/05/2008EP1987001A1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands
11/05/2008EP1986998A1 Metabotropic glutamate receptor-potentiating soindolones
11/05/2008EP1986994A2 Novel crystalline forms of armodafinil and preparation thereof
11/05/2008EP1986662A2 Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
11/05/2008EP1986658A2 Ibandronate new regimen for treating metastatic bone pain
11/05/2008EP1986647A2 4-acylaminopyridine derivative mediated neurogenesis
11/05/2008EP1986639A2 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of depression, anxiety, and neurodegenerative disorders
11/05/2008EP1986636A2 Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
11/05/2008EP1986627A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
11/05/2008EP1986623A2 Method for treatment of neuropathic pain
11/05/2008EP1986618A2 Adhesive preparation comprising sufentanil and methods of using the same
11/05/2008EP1824479B1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition
11/05/2008EP1781659B1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
11/05/2008EP1638969B1 Cgrp receptor antagonists
11/05/2008EP1597258B1 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use
11/05/2008EP1499596B1 Muscarinic antagonists
11/05/2008EP1385514B1 Spiroindene and spiroindane compounds
11/05/2008EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof
11/05/2008EP1309544B1 Compounds acting as melanocortin receptor ligands
11/05/2008EP1303278B1 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states
11/05/2008EP1270545B1 Process for producing amine derivatives
11/05/2008EP1218383B1 Bicyclic imidazo-5-yl-amine derivatives
11/05/2008EP0912601B2 Suppression of immune response via inhibition of cathepsin s
11/05/2008CN101300256A Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-but oxy]-3,4-dihydro-1H-[1,8]naphthyridin-2-one
11/05/2008CN101300253A Bicyclic derivatives as modulators of voltage gated ion channels
11/05/2008CN101300233A Azafused cyclin dependent kinase inhibitors
11/05/2008CN101300005A N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/05/2008CN101300002A Topical formulations containing O-desmethyl venlafaxine (ODV) or its salts
11/05/2008CN101298440A Pharmaceutical salts of reboxetine
11/05/2008CN101298433A 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
11/05/2008CN101297990A Regimen using padauk and health-preserving pillow
11/05/2008CN101297951A Pellet for soothing nerve and releasing depression
11/05/2008CN101297936A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297935A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297934A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297933A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297932A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297931A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297930A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297929A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297928A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297927A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297926A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297925A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297924A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297923A Pharmaceutical combination for preventing birth-defect and improving memory
11/05/2008CN101297922A Pharmaceutical combination for preventing birth-defect and improving memory
1 ... 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 ... 1833